Glaukos PE Ratio 2014-2023 | GKOS

Current and historical p/e ratio for Glaukos (GKOS) from 2014 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Glaukos PE ratio as of December 08, 2023 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Glaukos PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2023-12-08 63.63 0.00
2023-09-30 75.25 $-2.69 0.00
2023-06-30 71.21 $-2.64 0.00
2023-03-31 50.10 $-2.92 0.00
2022-12-31 43.68 $-2.09 0.00
2022-09-30 53.24 $-1.90 0.00
2022-06-30 45.42 $-1.19 0.00
2022-03-31 57.82 $-0.61 0.00
2021-12-31 44.44 $-1.08 0.00
2021-09-30 48.17 $-0.85 0.00
2021-06-30 84.83 $-1.33 0.00
2021-03-31 83.93 $-1.85 0.00
2020-12-31 75.26 $-2.73 0.00
2020-09-30 49.52 $-1.65 0.00
2020-06-30 38.42 $-1.67 0.00
2020-03-31 30.86 $-0.94 0.00
2019-12-31 54.47 $0.26 209.50
2019-09-30 62.51 $-0.54 0.00
2019-06-30 75.40 $-0.36 0.00
2019-03-31 78.37 $-0.34 0.00
2018-12-31 56.17 $-0.38 0.00
2018-09-30 64.90 $-0.39 0.00
2018-06-30 40.64 $-0.16 0.00
2018-03-31 30.83 $-0.11 0.00
2017-12-31 25.65 $-0.01 0.00
2017-09-30 33.00 $-0.04 0.00
2017-06-30 41.47 $-0.05 0.00
2017-03-31 51.30 $0.11 466.36
2016-12-31 34.30 $0.12 285.83
2016-09-30 37.74 $0.05 754.80
2016-06-30 29.16 $-0.05 0.00
2016-03-31 16.86 $-1.41 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $3.105B $0.283B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $189.233B 23.03
Intuitive Surgical (ISRG) United States $109.290B 73.04
DexCom (DXCM) United States $45.194B 86.64
IDEXX Laboratories (IDXX) United States $44.130B 54.22
Edwards Lifesciences (EW) United States $41.958B 27.56
IQVIA Holdings (IQV) United States $39.289B 23.45
Alcon (ALC) Switzerland $35.498B 29.15
STERIS (STE) Ireland $19.809B 24.01
SONOVA HOLDING (SONVY) Switzerland $17.886B 0.00
Waters (WAT) United States $17.273B 24.41
Hologic (HOLX) United States $16.409B 17.31
Fresenius Medical Care AG KGaA (FMS) Germany $12.106B 15.28
Sysmex ADR (SSMXY) Japan $11.574B 34.06
Teleflex (TFX) United States $10.861B 16.92
Penumbra (PEN) United States $8.647B 150.36
ShockWave Medical (SWAV) United States $6.427B 27.13
Globus Medical (GMED) United States $6.409B 20.05
Masimo (MASI) United States $5.514B 30.34
Inari Medical (NARI) United States $3.631B 0.00
Integra LifeSciences Holdings (IART) United States $3.226B 13.10
Elekta AB (EKTAY) Sweden $3.049B 23.38
Integer Holdings (ITGR) United States $2.984B 20.40
LivaNova (LIVN) United Kingdom $2.501B 16.88
TransMedics (TMDX) United States $2.380B 0.00
Pacific Biosciences Of California (PACB) United States $2.297B 0.00
Nihon Kohden (NHNKY) Japan $2.259B 18.82
PROCEPT BioRobotics (PRCT) United States $1.986B 0.00
Veracyte (VCYT) United States $1.871B 0.00
Alphatec Holdings (ATEC) United States $1.732B 0.00
Tandem Diabetes Care (TNDM) United States $1.566B 0.00
OPKO Health (OPK) United States $1.260B 0.00
RxSight (RXST) United States $1.254B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.982B 15.00
Paragon 28 (FNA) United States $0.950B 0.00
SiBone (SIBN) United States $0.783B 0.00
Artivion (AORT) United States $0.741B 90.35
Nevro (NVRO) United States $0.722B 0.00
OrthoPediatrics (KIDS) United States $0.713B 0.00
Treace Medical Concepts (TMCI) United States $0.586B 0.00
Mesa Laboratories (MLAB) United States $0.555B 17.28
IRadimed (IRMD) United States $0.526B 32.35
Pulse Biosciences (PLSE) United States $0.522B 0.00
CVRx (CVRX) United States $0.503B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.432B 0.00
Silk Road Medical (SILK) United States $0.379B 0.00
AxoGen (AXGN) United States $0.323B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 11.50
Semler Scientific (SMLR) United States $0.310B 18.02
AngioDynamics (ANGO) United States $0.277B 0.00
Accuray (ARAY) United States $0.257B 0.00
908 Devices (MASS) United States $0.226B 0.00
NeuroPace (NPCE) United States $0.221B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
EDAP TMS S.A (EDAP) France $0.191B 0.00
ClearPoint Neuro (CLPT) United States $0.165B 0.00
Sight Sciences (SGHT) United States $0.140B 0.00
Inogen (INGN) United States $0.138B 0.00
KORU Medical Systems (KRMD) United States $0.109B 0.00
Monogram Orthopaedics (MGRM) United States $0.108B 0.00
Pixie Dust Technologies (PXDT) Japan $0.106B 0.00
Atossa Genetics (ATOS) United States $0.094B 0.00
Hyperfine (HYPR) United States $0.086B 0.00
Spectral Diagnostics (EDTXF) Canada $0.082B 0.00
Accelerate Diagnostics (AXDX) United States $0.071B 0.00
Delcath Systems (DCTH) United States $0.066B 0.00
Yubo Biotech (YBGJ) China $0.061B 0.00
SEP Acquisition (SEPA) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.061B 0.00
Vasomedical (VASO) United States $0.060B 4.61
InspireMD (NSPR) Israel $0.055B 0.00
Eargo (EAR) United States $0.054B 0.00
Neuronetics (STIM) United States $0.053B 0.00
DarioHealth (DRIO) United States $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Spectral AI (MDAI) United States $0.047B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
ReWalk Robotics (RWLK) Israel $0.040B 0.00
Aspira Women's Health (AWH) United States $0.038B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Sensus Healthcare (SRTS) United States $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.028B 0.00
LENSAR (LNSR) United States $0.025B 0.00
PAVmed (PAVM) United States $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
PetVivo Holdings (PETV) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
T2 Biosystems (TTOO) United States $0.013B 0.00
NexGel (NXGL) United States $0.012B 0.00
Sientra (SIEN) United States $0.008B 0.00
Venus Concept (VERO) Canada $0.007B 0.00
Nemaura Medical (NMRD) United States $0.006B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00